Genomic Biomarkers For Risk Stratification In Prostate Cancer

MONTEREY, CA, USA (UroToday.com) - In his State-of-the-Art talk, Colin Collins discussed biomarkers for prostate cancer (CaP) risk stratification. He asked where genome copy number profiles can predict CaP recurrences. To explore this, his group used array comparative genomic hybridization (CGH) to identify genes mutations. The array data displays gene amplification and losses as topographical data.

More: continued here

Filed under: Cancer on November 2nd, 2008